Beam Therapeutics Plans to Build $83 Million Manufacturing Facility In North Carolina’s Research Triangle Park

Beam Therapeutics, a Boston-based biotechnology company developing precision medicines through DNA base editing, plans to build a $83 million manufacturing facility in North Carolina’s Research Triangle Park, it was announced today.

The uptick: the addition of 201 jobs with an average salary of around $102,654.

“North Carolina is a leader in biotechnology, from the research in our labs to the state’s biomanufacturers,” said Governor Roy Cooper, in a statement. “Companies like Beam Therapeutics’ work in developing precision medicines will help keep North Carolina on the cutting edge of this industry.”

Beam is developing precision genetic medicines through a pioneering CRISPR technology known as base editing. It’s using this proprietary gene editing approach to create therapies aimed at cures for serious diseases with precise edits to single base pairs in DNA and RNA.